These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2761783)

  • 41. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human germinal center B cells differ from naive and memory B cells by their aggregated MHC class II-rich compartments lacking HLA-DO.
    Chalouni C; Banchereau J; Vogt AB; Pascual V; Davoust J
    Int Immunol; 2003 Apr; 15(4):457-66. PubMed ID: 12663675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of HLA-DR expression on human myoblasts with interferon-gamma.
    Hohlfeld R; Engel AG
    Am J Pathol; 1990 Mar; 136(3):503-8. PubMed ID: 2107747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts.
    Hardiman O; Faustman D; Li X; Sklar RM; Brown RH
    Neurology; 1993 Mar; 43(3 Pt 1):604-8. PubMed ID: 8451007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
    Muczynski KA; Cotner T; Anderson SK
    Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.
    Bocelli-Tyndall C; Zajac P; Di Maggio N; Trella E; Benvenuto F; Iezzi G; Scherberich A; Barbero A; Schaeren S; Pistoia V; Spagnoli G; Vukcevic M; Martin I; Tyndall A
    Arthritis Rheum; 2010 Dec; 62(12):3815-25. PubMed ID: 20824797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory demyelination in a patient with CMT1A.
    Vital A; Vital C; Lagueny A; Ferrer X; Ribière-Bachelier C; Latour P; Petry KG
    Muscle Nerve; 2003 Sep; 28(3):373-6. PubMed ID: 12929199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
    Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
    J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human fetal Schwann cells in culture: phenotypic expressions and proliferative capability.
    Kim SU; Yong VW; Watabe K; Shin DH
    J Neurosci Res; 1989 Jan; 22(1):50-9. PubMed ID: 2538639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA in Charcot-Marie-Tooth disease.
    Williams LL
    Ann Neurol; 1980 Oct; 8(4):452. PubMed ID: 7436389
    [No Abstract]   [Full Text] [Related]  

  • 54. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A.
    Hanemann CO; D'Urso D; Gabreëls-Festen AA; Müller HW
    Brain; 2000 May; 123 ( Pt 5)():1001-6. PubMed ID: 10775544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drosophila Charcot-Marie-Tooth Disease Models.
    Yamaguchi M; Takashima H
    Adv Exp Med Biol; 2018; 1076():97-117. PubMed ID: 29951817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: evidence for a Schwann cell actinopathy.
    Mathis S; Funalot B; Boyer O; Lacroix C; Marcorelles P; Magy L; Richard L; Antignac C; Vallat JM
    J Neuropathol Exp Neurol; 2014 Mar; 73(3):223-33. PubMed ID: 24487800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.